Time to definitive treatment in rectal cancer care coordination

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery Pub Date : 2025-04-02 DOI:10.1016/j.amjsurg.2025.116333

Alexis L. Woods , Axenya Kachen , Rebeka A. Dejenie , Sean M. Flynn , Robert J. Kucejko , Erik R. Noren , Ankit Sarin , Miquell Miller

{"title":"Time to definitive treatment in rectal cancer care coordination","authors":"Alexis L. Woods , Axenya Kachen , Rebeka A. Dejenie , Sean M. Flynn , Robert J. Kucejko , Erik R. Noren , Ankit Sarin , Miquell Miller","doi":"10.1016/j.amjsurg.2025.116333","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Timely initiation of rectal cancer treatment improves outcomes, and standard of care is to receive definitive treatment within 60 days of diagnosis.</div></div><div><h3>Methods</h3><div>A retrospective review of rectal cancer patients (2013–2023) at a tertiary cancer center was performed. Statistical analysis was conducted on patients stratified to time-to-treatment within 60 days and patient sociodemographics.</div></div><div><h3>Results</h3><div>182/342 (53.2 %) rectal cancer patients had time-to-treatment ≤60 days. Unified care was significantly faster than fragmented care (57.5 vs 77.4 days, p = 0.002). Factors associated with time-to-treatment >60 days: sex (p = 0.03), age (p = 0.004), insurance (p = 0.006), Healthy Places Index quintile (p = 0.02), distance from hospital (p = 0.01). Multivariable analysis associated delays with females (OR 1.74 [95 % CI 1.05–2.91],p = 0.03), and living >60 miles from the hospital (60–100 miles OR 2.49 [95 % CI 1.09–5.85],p = 0.03; >100 miles OR 2.87 [95 % CI 1.05–8.25],p = 0.04).</div></div><div><h3>Conclusion</h3><div>In this study, 46.8 % of rectal cancer patients initiated definitive treatment >60 days from diagnosis. Unified care improved time-to-treatment. Female sex and living >60 miles from the hospital were associated with delays.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"248 ","pages":"Article 116333"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002961025001552","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Timely initiation of rectal cancer treatment improves outcomes, and standard of care is to receive definitive treatment within 60 days of diagnosis.

Methods

A retrospective review of rectal cancer patients (2013–2023) at a tertiary cancer center was performed. Statistical analysis was conducted on patients stratified to time-to-treatment within 60 days and patient sociodemographics.

Results

182/342 (53.2 %) rectal cancer patients had time-to-treatment ≤60 days. Unified care was significantly faster than fragmented care (57.5 vs 77.4 days, p = 0.002). Factors associated with time-to-treatment >60 days: sex (p = 0.03), age (p = 0.004), insurance (p = 0.006), Healthy Places Index quintile (p = 0.02), distance from hospital (p = 0.01). Multivariable analysis associated delays with females (OR 1.74 [95 % CI 1.05–2.91],p = 0.03), and living >60 miles from the hospital (60–100 miles OR 2.49 [95 % CI 1.09–5.85],p = 0.03; >100 miles OR 2.87 [95 % CI 1.05–8.25],p = 0.04).

Conclusion

In this study, 46.8 % of rectal cancer patients initiated definitive treatment >60 days from diagnosis. Unified care improved time-to-treatment. Female sex and living >60 miles from the hospital were associated with delays.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of surgery 医学-外科

CiteScore

5.00

自引率

6.70%

发文量

570

审稿时长

56 days

期刊介绍： The American Journal of Surgery® is a peer-reviewed journal designed for the general surgeon who performs abdominal, cancer, vascular, head and neck, breast, colorectal, and other forms of surgery. AJS is the official journal of 7 major surgical societies* and publishes their official papers as well as independently submitted clinical studies, editorials, reviews, brief reports, correspondence and book reviews.